The Australian biotechnology industry is in the midst of uncertain times, not only due to the gene patenting debate in Australia but also in the wake of events unfolding in the USA. [ + ]

Sirtex Medical (ASX:SRX) posts $3.6 million profit on the back of increased sales in the face of currency bump. [ + ]

The Australian and Mongolian academies of science have signed a memorandum of understanding, in order to increase collaboration.

Mathematicians are creating a periodic table that will provide a directory of all the possible shapes in the universe across three, four and five dimensions.

An investigation will begin into the international efforts to eliminate or restrict the use of POPs, when CSIRO starts a new atmospheric monitoring program.

Professor Lindoy at the University of Sydney has created a new type of molecular structure, based on aesthetics.

Andrew Lawrence’s team has made a crucial discovery about the molecular mechanism of relapsing addiction, which might help fight the scourge of drug addiction. [ + ]

Animal models can reveal how addicts respond to environmental cues, triggering relapse. [ + ]

Florey Neuroscience Institutes’ Professor Andrew Lawrence is hot on the trail of treatments for addiction. [ + ]

QRxPharma (ASX:QRX) will meet with the FDA for a pre-NDA meeting following positive results from pivotal phase III trial of MoxDuo. [ + ]

The Chief Scientist for Australia, Professor Penny Sackett, has resigned.

Australia's Chief Scientist, Professor Penny Sackett, has stunned the scientific community with her sudden resignation today. [ + ]

Nominations are now open for the prestigious Prime Minister's Prizes for Science. [ + ]

CSIRO joins the global battle against bird flu and other mutating viruses.

Acquisitions are commonplace in the IT industry. ARN investigates what makes the difference between a successful acquisition or merger, and where things can (and do) go wrong. [ + ]